Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: A comparison with allografts from adult unrelated donors

Haematologica

Volumn 99, Issue 2, 2014, Pages 322-328

  Marks, David I ^a   Woo, Kwang Ahn ^b   Zhong, Xiaobo ^b   Appelbaum, Frederick R ^c   Bachanova, Veronika ^d   Barker, Juliet N ^e   Brunstein, Claudio G ^d   Gibson, John ^f   Kebriaei, Partow ^g   Lazarus, Hillard M ^h   Olsson, Richard ⁱ   Perales, Miguel Angel ^e   Pidala, Joseph ^j   Savani, Bipin ^k   Rocha, Vanderson ^l   Eapen, Mary ^b  

^a UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h CASE WESTERN RESERVE UNIVERSITY   (United States)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^l CHURCHILL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEUTROPHIL; OVERALL SURVIVAL; SURVIVAL RATE; THROMBOCYTE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; ALLOGRAFTS; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; SURVIVAL RATE; UNRELATED DONORS;

EID: 84896710891     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.094193     Document Type: Article

References (28)

1. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/ maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2008;111(4):1827-33.
2. Marks DI, Perez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, et al. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 2008;112(2):426-34.
3. Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G, et al. Outcome of 609 adults after relapse of acute lymphoblastic leukaemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood. 2007;109 (3):944-50.
4. Gokbuget N, Kneba M, Raff T, Trautmann H, Bartram CR, Arnold R, et al. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies; German multi-center study group for adult acute lymphoblastic leukemia. Blood. 2012;120(9):1868-76.
5. Marks DI, Forman SJ, Blume KG, Perez W, Weisdorf DJ, Keating A, et al. A comparison of cyclophosphamide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant. 2006;12(4):438-43.
6. Marks DI, Wang T, Perez WS, Antin JH, Copelan E, Gale RP, et al. The outcomes of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood. 2010;116(3): 366-74.
7. Mohty M, Labopin M, Volin L, Gratwohl A, Socie G, Esteve J, et al. Reduced intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. 2010;116 (22):4439-43.
8. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351(22):2265-75.
9. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351(22): 2276-85.
10. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, et al. Effect of graft source of unrelated donor hematopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analysis. Lancet Oncol. 2010;11(7):653-60.
11. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15(12):1628-33.
12. Przepiorka D, Weisdorf DJ, Martin P, Klingemann HG, Beatty O, Hows J, et al. 1994 Concensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15(6):825-8.
13. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am. 1999;13(5):1091-112.
14. Klein JP, Moeschberger ML. Survival analysis: techniques of censored and truncated data 2nd ed. New York: Springer-Verlag, 2003.
15. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statist Med. 1999;18(6):695-706.
16. Cox DR. Regression model and life tables. J R Stat Soc B. 1972;34(2):187-200.
17. Scaradavou A, Brunstein C, Eapen M, Le-Rademacher J, Barker JN, Chao N, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 2013;121(5):752-8.
18. Andersen PK, Klein JP, Zhang M-J. Testing for center effects in multi-center survival studies: a Monte Carlo comparison of fixed and random effects tests. Statist Med. 1999; 18(12):1489-500.
19. Atsuta Y, Suzuki R, Nagamura-Inoue, Taniguchi S, Takahashi S, Kai S, et al. Disease specific analyses of unrelated cord blood transplantation compared to unrelated bone marrow transplantation in adults with acute leukemia. Blood. 2009;113(8): 1631-8.
20. Nishiwaki S, Miyamura K, Ohashi K, Kurokawa M, Taniguchi S, Fukuda T, et al. Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Ann Oncol. 2013;24(6): 1594-602.
21. Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen KK, et al. Race and socioeconomic status influence outcomes of unrelated hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15(12):1543-54.
22. Passweg JR, Cahn J-Y, Tiberghien P, Vowels MR, Camitta BM, Gale RP, et al. Graft versus leukemia effect in T-lineage and cALLa+ (-lineage) acute lymphoblastic leukemia. Bone Marrow Transplant. 1998; 21(2):153-8.
23. Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, et al. Effect of donorrecipient HLA matching at HLA-A, B, C and DRB1 on outcomes after umbilical cord blood transplantation for leukemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol. 2011;12 (13):1214-21.
24. Eapen M, Klein JP, Ruggeri A, Spellman S, Arcese W, Baxter-Lowe L, et al. Is allelelevel HLA-matching relevant for single umbilical cord blood transplants? Bone Marrow Transplant. 2013;092a.
25. Barker JN, Weisdorf DI, DeFor TE, Blazar BR, McGlave PB, Miller JS, et al. Transplantation of two partially matched HLA-matched umbilical cord blood units to enhance engraftment in adults with haematological malignancy. Blood. 2005;105(3): 1343-7.
26. Brunstein CG, Gutman JA, Weisdorf DJ, Woolfry AE, DeFor TE, Gooley TA, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood. 2010;116(22):4693-9.
27. Luznik L, Bolanos-Meade J, Zahurak A, Chen AR, Smith BD, Brodsky R, et al. Highdose cyclophosphamide as single-agent short-course prophylaxis of graft-versushost disease. Blood. 2010;115(16): 3224-30.
28. Marks DI, Aversa F, Lazarus HM. Alternative donor transplants for acute lymphoblastic leukemia: a comparison of the three major options. Bone Marrow Transplant. 2006;38(7):467-75.